There have been multiple accounts created with the sole purpose of posting advertisement posts or replies containing unsolicited advertising.

Accounts which solely post advertisements, or persistently post them may be terminated.

autotldr Bot ,

This is the best summary I could come up with:


The UK has become the first country to approve a therapy based on Crispr gene editing, with the regulator authorizing a treatment for sickle cell disease and beta thalassemia.

The UK regulator has promised to focus on speeding the most innovative treatments to market after being given permission from next year to cut its workload by following other countries’ recommendations on approvals of other drugs.

Crispr is a flexible and efficient gene editing tool based on the bacterial immune system, which has sped from the initial discovery to an approved drug in just 11 years.

Scientists Jennifer Doudna and Emmanuelle Charpentier showed that Crispr could be used to disrupt, delete, or correct genetic errors in 2012, leading to a Nobel Prize in 2020.

The MHRA is hoping to attract makers of novel treatments to the UK, despite the country representing only just over 2 percent of the global drug market, far smaller than when it was part of the EU.

In the spring Budget, UK chancellor Jeremy Hunt gave the agency an extra £10mn in funding over two years to “put in place the quickest, simplest, regulatory approval in the world for companies seeking rapid market access.”


The original article contains 498 words, the summary contains 197 words. Saved 60%. I’m a bot and I’m open source!

  • All
  • Subscribed
  • Moderated
  • Favorites
  • [email protected]
  • random
  • lifeLocal
  • goranko
  • All magazines